You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • ITP
  • autologous anti-BCMA chimeric antigen receptor T cells
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2022-03-31
Mar 31, 2022
M
Recruiting
  • Hematologic Malignancy
  • CAR-T Cell Therapy
  • Educational Video Tool
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-08-31
Aug 31, 2021
C
Withdrawn
  • Blood Cancer
  • Psychoeducation
  • (no location specified)
2021-07-14
Jul 14, 2021
M
Recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-01-19
Jan 19, 2022
N
Recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +6 more
  • CAR T-cell therapy
  • Singapore, Singapore
    Allen Yeoh Eng Juh
2021-09-07
Sep 7, 2021
N
Not yet recruiting
  • Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
  • +18 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +3 more
  • Chicago, Illinois
  • +2 more
2022-01-18
Jan 18, 2022
N
Recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +5 more
  • CAR T-cell therapy
  • Singapore, Singapore
    Allen Yeoh Eng Juh
2021-09-07
Sep 7, 2021
N
Not yet recruiting
  • Lymphoma
  • Leukemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    C
    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    2021-09-13
    Sep 13, 2021
    H
    Recruiting
    • Relapsed and Refractory
    • Lymphoid Hematological Malignancies
    • CD20/CD22 dual Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    2020-08-20
    Aug 20, 2020
    T
    Recruiting
    • Refractory and Relapsed T Cell Lymphoma
    • Humanized CD7 CAR-T cells
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    2021-09-17
    Sep 17, 2021
    M
    Not yet recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +6 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    2022-02-18
    Feb 18, 2022
    D
    Recruiting
    • Stem Cell Transplant
    • +8 more
    • Education
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    2021-04-16
    Apr 16, 2021
    M
    Recruiting
    • Malignant Pleural Mesothelioma (MPM)
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    2021-07-19
    Jul 19, 2021
    A
    Terminated
    • Acute Myeloid Leukemia
    • Multiple Myeloma
    • MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
    • Ostrava, Czech Republic, Czechia
    • +2 more
    2021-12-20
    Dec 20, 2021
    D
    Recruiting
    • Lymphoma
    • Lymphoma Cns
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    2021-10-12
    Oct 12, 2021
    T
    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • +2 more
    • Humanized CD7 CAR-T cells
    • Suzhou, (Select), China
      The First Affiliated Hospital of Soochow University
    2021-06-01
    Jun 1, 2021
    T
    Recruiting
    • Multiple Myeloma
    • clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    2021-10-22
    Oct 22, 2021
    M
    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Chimeric Antigen Receptor T-Cell Therapy
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    2022-03-08
    Mar 8, 2022
    T
    Recruiting
    • Acute Myeloid Leukemia
    • anti-CLL1 CART
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    2021-05-10
    May 10, 2021
    U
    Recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2022-03-16
    Mar 16, 2022
    A
    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • Leukapheresis
    • +2 more
    • La Jolla, California
    • +4 more
    2022-03-21
    Mar 21, 2022
    J
    Recruiting
    • CD19 Positive
    • +13 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +3 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    2021-08-10
    Aug 10, 2021
    B
    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD7.CAR/28zeta CAR T cells
    • +2 more
    • Houston, Texas
    • +1 more
    2021-12-15
    Dec 15, 2021